314 related articles for article (PubMed ID: 35568522)
1. Cognitive Dysfunction and Prefrontal Cortical Circuit Alterations in Schizophrenia: Developmental Trajectories.
Dienel SJ; Schoonover KE; Lewis DA
Biol Psychiatry; 2022 Sep; 92(6):450-459. PubMed ID: 35568522
[TBL] [Abstract][Full Text] [Related]
2. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.
Lewis DA; Curley AA; Glausier JR; Volk DW
Trends Neurosci; 2012 Jan; 35(1):57-67. PubMed ID: 22154068
[TBL] [Abstract][Full Text] [Related]
3. Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia.
Hoftman GD; Datta D; Lewis DA
Biol Psychiatry; 2017 May; 81(10):862-873. PubMed ID: 27455897
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia.
Enwright Iii JF; Huo Z; Arion D; Corradi JP; Tseng G; Lewis DA
Mol Psychiatry; 2018 Jul; 23(7):1606-1613. PubMed ID: 29112193
[TBL] [Abstract][Full Text] [Related]
5. Altered Parvalbumin Basket Cell Terminals in the Cortical Visuospatial Working Memory Network in Schizophrenia.
Fish KN; Rocco BR; DeDionisio AM; Dienel SJ; Sweet RA; Lewis DA
Biol Psychiatry; 2021 Jul; 90(1):47-57. PubMed ID: 33892915
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders.
Arion D; Huo Z; Enwright JF; Corradi JP; Tseng G; Lewis DA
Biol Psychiatry; 2017 Oct; 82(8):594-600. PubMed ID: 28476208
[TBL] [Abstract][Full Text] [Related]
7. Mapping pathologic circuitry in schizophrenia.
Glausier JR; Lewis DA
Handb Clin Neurol; 2018; 150():389-417. PubMed ID: 29496154
[TBL] [Abstract][Full Text] [Related]
8. Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia.
Datta D; Arnsten AFT
ACS Chem Neurosci; 2018 Sep; 9(9):2127-2145. PubMed ID: 29470055
[TBL] [Abstract][Full Text] [Related]
9. Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia.
Georgiev D; Arion D; Enwright JF; Kikuchi M; Minabe Y; Corradi JP; Lewis DA; Hashimoto T
Am J Psychiatry; 2014 Jan; 171(1):62-71. PubMed ID: 24170294
[TBL] [Abstract][Full Text] [Related]
10. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
Lewis DA; Volk DW; Hashimoto T
Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
[TBL] [Abstract][Full Text] [Related]
11. Early NMDA Receptor Ablation in Interneurons Causes an Activity-Dependent E/I Imbalance in vivo in Prefrontal Cortex Pyramidal Neurons of a Mouse Model Useful for the Study of Schizophrenia.
Pafundo DE; Pretell Annan CA; Fulginiti NM; Belforte JE
Schizophr Bull; 2021 Aug; 47(5):1300-1309. PubMed ID: 33822178
[TBL] [Abstract][Full Text] [Related]
12. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.
Lewis DA; Moghaddam B
Arch Neurol; 2006 Oct; 63(10):1372-6. PubMed ID: 17030651
[TBL] [Abstract][Full Text] [Related]
13. Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development.
Schoonover KE; Dienel SJ; Lewis DA
Biomark Neuropsychiatry; 2020 Dec; 3():. PubMed ID: 32656540
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration.
Chamberlin LA; Yang SS; McEachern EP; Lucas JTM; McLeod Ii OW; Rolland CA; Mack NR; Ferguson BR; Gao WJ
Neuropsychopharmacology; 2023 Aug; 48(9):1267-1276. PubMed ID: 37041206
[TBL] [Abstract][Full Text] [Related]
15. Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.
Glausier JR; Fish KN; Lewis DA
Mol Psychiatry; 2014 Jan; 19(1):30-6. PubMed ID: 24217255
[TBL] [Abstract][Full Text] [Related]
16. Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.
Chung DW; Fish KN; Lewis DA
Am J Psychiatry; 2016 Nov; 173(11):1131-1139. PubMed ID: 27444795
[TBL] [Abstract][Full Text] [Related]
17. Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution.
Dienel SJ; Enwright JF; Hoftman GD; Lewis DA
Schizophr Res; 2020 Mar; 217():86-94. PubMed ID: 31296415
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic Effects of N-Methyl-D-Aspartate Receptors Enhance Parvalbumin Cell-Mediated Inhibition of Pyramidal Cells in Mouse Prefrontal Cortex.
Pafundo DE; Miyamae T; Lewis DA; Gonzalez-Burgos G
Biol Psychiatry; 2018 Sep; 84(6):460-470. PubMed ID: 29523414
[TBL] [Abstract][Full Text] [Related]
19. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
Kimoto S; Zaki MM; Bazmi HH; Lewis DA
JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
[TBL] [Abstract][Full Text] [Related]
20. Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome.
Zorrilla de San Martin J; Donato C; Peixoto J; Aguirre A; Choudhary V; De Stasi AM; Lourenço J; Potier MC; Bacci A
Elife; 2020 Aug; 9():. PubMed ID: 32783810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
